Business
Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth
Continued organic quarter over quarter revenue growth despite expected summer seasonalityEarnings per share for Q3, 2025: ($0.05) per share.Oversubscribed raise of C$4.23m contributing to significantly improved cash position.Announced signed in-network contracts and credentialing with several major U.S. insurance companies. Extending Rocket Doctor’s U.S. total in-network reach to over 13 million members. Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (former
About this update from Rocket Doctor Ai Inc
[{"type":"image","alt":"Rocket Doctor AI Inc.","displaySize":"","headline":null,"caption":"Rocket Doctor AI Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":51,"url":"https://media.zenfs.com/en/globenewswire.com/c58fe9f46edab2ec99ef29959709ece6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9TxOvIQs41xEIKPOqbddMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTcxO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/c58fe9f46edab2ec99ef29959709ece6","width":300,"height":51}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Continued organic quarter over quarter revenue growth despite expected summer seasonality","length":89,"tagName":"p"}]},{"val":[{"type":"text","content":"Earnings per share for Q3, 2025: ($0.05) per share.","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"Oversubscribed raise of C$4.23m contributing to significantly improved cash position.","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Announced signed in-network contracts and credentialing with several major U.S. insurance companies. Extending Rocket Doctor’s U.S. total in-network reach to over 13 million members.","length":182,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":407,"olType":false},{"type":"text","content":"Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) is pleased to announce its financial results for the third quarter ended September 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.Dr. Essam Hamza, Chief Executive Officer of Rocket Doctor AI Inc., added: ”Despite expected summer seasonality, we are pleased to report continued sequential organic revenue growth in Q3 compared to Q2. This financial stability, coupled with a successfully oversubscribed capital raise of $4.23 million, underscores investor confidence. Crucially, the period also saw us announce pivotal 'in-network' new payer agreements in the U.S., These new agreements expand Rocket Doctor Inc’s ability to now deliver care to more than 13 million insured members across California, Maryland and New York State. With the U.S. currently representing ~ 5% of our revenue today, this significant network build positions us for ac...